| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.07 | 0.01 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |